AstraZeneca PLC (ETR:ZEG)
134.30
-0.35 (-0.26%)
Aug 15, 2025, 5:35 PM CET
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
€510,187
Profits / Employee
€74,901
Market Cap
208.29B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
AstraZeneca News
- 1 day ago - FLUMIST (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery - Wallstreet:Online
- 1 day ago - FLUMIST (Influenza, Vaccine Live, Intranasal), the nation's only nasal spray flu vaccine, now available for home delivery - Benzinga
- 1 day ago - George Soros Exits AstraZeneca PLC, Impacting Portfolio by -3.98% - GuruFocus
- 3 days ago - The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact - PRNewsWire
- 4 days ago - UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Benzinga
- 5 days ago - AstraZeneca: Great Portfolio, But Not A Great Price - Seeking Alpha
- 7 days ago - Melrose boss soars to top of the Footsie pay league - This is Money
- 9 days ago - Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG) - Benzinga